We are live on ! Find out more
3C

361 Capital Portfolio holdings

AUM $213M
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+35.34%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
10 Year Est. Return
AUM
$213M
AUM Growth
-$6.7M
Cap. Flow
-$47.5M
Cap. Flow %
-22.27%
Top 10 Hldgs %
8.05%
Holding
403
New
118
Increased
30
Reduced
151
Closed
104

Top Buys

Rank Stock Value
1
LEA icon
Lear
LEA
+$1.16M
2
COLD icon
Americold
COLD
+$1.09M
3
RSG icon
Republic Services
RSG
+$1.07M
4
HWM icon
Howmet Aerospace
HWM
+$1.07M
5
ICE icon
Intercontinental Exchange
ICE
+$911K

Top Sells

Rank Stock Value
1
CHE icon
Chemed
CHE
+$1.96M
2
HELE icon
Helen of Troy
HELE
+$1.64M
3
FCN icon
FTI Consulting
FCN
+$1.55M
4
SR icon
Spire
SR
+$1.54M
5
MCK icon
McKesson
MCK
+$1.54M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 16.28%
3 Financials 11.74%
4 Industrials 10.63%
5 Consumer Discretionary 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THC icon
151
Tenet Healthcare
THC
$21.2B
$715K 0.34%
+39,482
New +$778K
FBC
152
DELISTED
Flagstar Bancorp, Inc. New
FBC
$715K 0.34%
24,288
-3,772
-13% -$96.6K
LNG icon
153
Cheniere Energy
LNG
$54.6B
$710K 0.33%
+14,694
New +$642K
BECN
154
DELISTED
Beacon Roofing Supply, Inc.
BECN
$708K 0.33%
+26,852
New +$600K
SCHA icon
155
Schwab U.S Small- Cap ETF
SCHA
$22.4B
$707K 0.33%
43,260
+5,856
+16% +$87.7K
PSMT icon
156
Pricesmart
PSMT
$5.8B
$706K 0.33%
11,707
-1,817
-13% -$105K
TERP
157
DELISTED
TerraForm Power, Inc
TERP
$703K 0.33%
+38,100
New +$674K
EVBG
158
DELISTED
Everbridge, Inc. Common Stock
EVBG
$699K 0.33%
+5,054
New +$657K
IDCC icon
159
InterDigital
IDCC
$6.65B
$697K 0.33%
+12,312
New +$655K
AWR icon
160
American States Water
AWR
$3.37B
$694K 0.33%
8,825
-1,370
-13% -$109K
NUVA
161
DELISTED
NuVasive, Inc.
NUVA
$690K 0.32%
12,396
-1,924
-13% -$111K
HCAT icon
162
Health Catalyst
HCAT
$160M
$688K 0.32%
23,599
-3,683
-13% -$102K
XNCR icon
163
Xencor
XNCR
$1.47B
$688K 0.32%
+21,230
New +$651K
TBPH icon
164
Theravance Biopharma
TBPH
$875M
$686K 0.32%
32,680
-5,074
-13% -$130K
PETS icon
165
PetMed Express
PETS
$41.9M
$681K 0.32%
+19,106
New +$663K
HR
166
DELISTED
Healthcare Realty Trust Incorporated
HR
$675K 0.32%
+23,032
New +$689K
SWX icon
167
Southwest Gas
SWX
$6.68B
$673K 0.32%
+9,742
New +$709K
CTMX icon
168
CytomX Therapeutics
CTMX
$740M
$671K 0.31%
+80,556
New +$748K
HPQ icon
169
HP
HPQ
$24.1B
$671K 0.31%
+38,522
New +$612K
BBY icon
170
Best Buy
BBY
$18.7B
$670K 0.31%
7,683
-2,505
-25% -$190K
PDM
171
Piedmont Realty Trust
PDM
$1.22B
$670K 0.31%
+40,332
New +$673K
SCHZ icon
172
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$669K 0.31%
23,808
+296
+1% +$8.24K
FRTA
173
DELISTED
Forterra, Inc
FRTA
$669K 0.31%
59,925
-9,317
-13% -$76.9K
ADNT icon
174
Adient
ADNT
$1.61B
$667K 0.31%
+40,646
New +$618K
AAON icon
175
Aaon
AAON
$8.19B
$663K 0.31%
+18,309
New +$615K

Similar funds

361 Capital's Q2 2020 Portfolio in Review

As of Q2 2020, 361 Capital held 403 positions worth $213M, down 3% from $220M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

361 Capital withdrew a net $47.5M in Q2 2020, closing 104 positions and reducing 151 holdings. Its most notable exit was Chemed, an estimated $1.96M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, 361 Capital opened a new position in Lear worth $1.27M.

  • 361 Capital's largest Q2 2020 buy was Lear: 11,650 shares worth $1.27M.
  • 361 Capital added most to DaVita in Q2 2020, an estimated $427K increase.
  • 361 Capital's biggest Q2 2020 reduction was Williams Companies, cutting an estimated $1.41M.
  • 361 Capital fully exited Chemed in Q2 2020, selling an estimated $1.96M.
  • 361 Capital's ten largest holdings make up 8.1% of its $213M portfolio in Q2 2020.
  • 361 Capital opened 118 new positions and closed 104 in Q2 2020.
  • 361 Capital's portfolio value fell 3% quarter-over-quarter to $213M.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.